12-68686678-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000502102.2(NUP107-DT):n.822+256G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 211,878 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0096 ( 14 hom., cov: 33)
Exomes 𝑓: 0.012 ( 9 hom. )
Consequence
NUP107-DT
ENST00000502102.2 intron
ENST00000502102.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.22
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 12-68686678-C-T is Benign according to our data. Variant chr12-68686678-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1320404.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 14 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOC100507250 | NR_038930.1 | n.123+59G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUP107-DT | ENST00000502102.2 | n.822+256G>A | intron_variant | 1 | ||||||
NUP107-DT | ENST00000433116.2 | n.101+59G>A | intron_variant | 2 | ||||||
NUP107-DT | ENST00000500695.2 | n.123+59G>A | intron_variant | 5 | ||||||
NUP107-DT | ENST00000690517.1 | n.140+59G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00963 AC: 1466AN: 152246Hom.: 14 Cov.: 33
GnomAD3 genomes
AF:
AC:
1466
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0124 AC: 739AN: 59514Hom.: 9 AF XY: 0.0127 AC XY: 389AN XY: 30662
GnomAD4 exome
AF:
AC:
739
AN:
59514
Hom.:
AF XY:
AC XY:
389
AN XY:
30662
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00962 AC: 1465AN: 152364Hom.: 14 Cov.: 33 AF XY: 0.00921 AC XY: 686AN XY: 74506
GnomAD4 genome
AF:
AC:
1465
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
686
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 23, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at